Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: muddphudd who wrote (1326)	10/25/1998 12:22:00 PM
From: DavidCG	Read Replies (1) \| Respond to of 2135

Human trials/testing will take place WITHIN 1 year. You must mean you're guessing 2 years to market by being fast tracked by the FDA because human trials will start far before that. From the latest news report by Bloomberg: >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> A new study of EntreMed's Endostatin is slated to be presented at the Clinical Congress of the American College of Surgeons, being held in Orlando, Florida next week. The study, done in genetically engineered mice, is expected to confirm results of earlier animal research indicating Endostatin is a potent tumor shrinker, said Mary Sundeen, director of research operations and communications at EntreMed. "The first-ever human trials are set to start within the next 12 months, Sundeen said." >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> "Within the next 12 months" implies that human trials may start BEFORE 12 months from now...and that is really exciting and much sooner than I had anticipated. I thought maybe your conversation might have revealed how soon within the next twelve months human trials might start. Thank you. -DavidCG